Chardan Capital Issues Optimistic Forecast for DRUG Earnings
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Free Report) – Equities research analysts at Chardan Capital lifted their FY2025 earnings per share estimates for shares of Bright Minds Biosciences in a report released on Wednesday, May 21st. Chardan Capital analyst R. Li now anticipates that the company will earn ($1.23) per share for the year, up […]
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Free Report) – Equities research analysts at Chardan Capital lifted their FY2025 earnings per share estimates for shares of Bright Minds Biosciences in a report released on Wednesday, May 21st. Chardan Capital analyst R. Li now anticipates that the company will earn ($1.23) per share for the year, up […]
